For instance, Gentile and Garcovich reported that adding dihydrotestosterone (DHT) to DPCs from patients with androgenic alopecia decreases the expression of FGF7 within cells while increasing the secretion of both FGF7 and FGF2 [135]. Here, FGF2 is linked to androgenetic alopecia.